Biotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21st
February 19, 2024
DAXOR AWARDED NEW PATENT FOR BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES
January 4, 2022
Related Post
-
-
Biotricity Advances Towards Breakeven Milestone – Set to Announce Record Margins and Operational Efficiency for Third Quarter of Fiscal Year 2024
February 14, 2024
-
Petros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Provider
February 14, 2024
-
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN VETERINARY CONFERENCE IN LAS VEGAS, NEVADA
February 13, 2024